Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
27.94
-0.63 (-2.19%)
At close: Apr 28, 2026, 4:00 PM EDT
27.94
+0.01 (0.02%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Zymeworks Employees
Zymeworks had 264 employees as of December 31, 2025. The number of employees decreased by 22 or -7.69% compared to the previous year.
Employees
264
Change (1Y)
-22
Growth (1Y)
-7.69%
Revenue / Employee
$401,383
Profits / Employee
-$307,311
Market Cap
2.06B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 835 |
| Ascentage Pharma Group International | 767 |
| Adaptive Biotechnologies | 624 |
| Ocular Therapeutix | 325 |
| Capricor Therapeutics | 231 |
| Stoke Therapeutics | 170 |
| Aurinia Pharmaceuticals | 128 |
| Definium Therapeutics | 106 |
ZYME News
- 7 days ago - Zymeworks Presents New Phase 1 Data for ZW191, a Folate Receptor Alpha-Targeting ADC at AACR Annual Meeting 2026 - GlobeNewsWire
- 7 days ago - Zymeworks Transcript: 2026 Bloom Burton & Co. Healthcare Investor Conference - Transcripts
- 11 days ago - Zymeworks Presents New Preclinical Data at AACR 2026 Highlighting Broad Antibody-Drug Conjugate Programs Including Novel RAS-Targeting Platform - GlobeNewsWire
- 12 days ago - Zymeworks to Report First Quarter 2026 Financial Results and Host Conference Call on May 7, 2026 - GlobeNewsWire
- 13 days ago - Zymeworks Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 19 days ago - Zymeworks Announces Additional Leadership Appointments to Advance Next Phase of Growth - GlobeNewsWire
- 27 days ago - Zymeworks Appoints Kristin Stafford as Chief Financial Officer - GlobeNewsWire
- 4 weeks ago - Zymeworks Receives U.S. FDA Fast Track Designation for ZW191, an FRα-Targeting Antibody-Drug Conjugate - GlobeNewsWire